SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Teva Pharmaceuticals
TEVA 20.48+2.2%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: kanta who wrote (278)2/28/2001 2:58:58 AM
From: Dorine Essey   of 340
 
Market Report -- In Play (TEVA)
February 27, 2001 11:26:00 AM ET

Teva Pharm (TEVA) 64 7/16 +2 1/4 (+3.6%): -- Technical -- Has broken through its 50/100/200 moving averages in early week action but has stopped shy of its 2001 recovery high (also a retracement target) at 66. Is overextended short term but no intraday damage while support at 63 is intact. Broad consolidation range provides next resistance between 67-69.

Briefing.com is the leading Internet provider of live market analysis for U.S. Stock, U.S. Bond, and world FX market participants.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext